This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gritz, L Articles by Panicali, D Search for Related Content PubMed PubMed Citation Articles by Gritz, L Articles by Panicali, D

 Previous Article  |  Next Article 

J Virol. 1990 December; 64(12): 5948-5957

Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Applied bioTechnology, Inc, Cambridge, Massachusetts 02142.

ABSTRACT

The ability of poxviruses to undergo intramolecular recombination within tandemly arranged homologous sequences can be used to generate chimeric genes and proteins. Genes containing regions of nucleotide homology will recombine to yield a single sequence composed of portions of both original genes. A recombinant virus containing two genes with a number of conserved regions will yield a population of recombinant viruses containing a spectrum of hybrid sequences derived by recombination between the original genes. This scheme has been used to generate hybrid human immunodeficiency virus type 1 env genes. Recombinant vaccinia viruses that contain two divergent env genes in tandem array have been constructed. In the absence of selective pressure to maintain both genes, recombination between conserved homologous regions in these genes generated a wide range of progeny, each of which expressed a novel variant polypeptide encoded by the newly created hybrid env gene. Poxvirus-mediated recombination may be applied to map type-specific epitopes, to create novel pharmaceuticals such as hybrid interferons, to study receptor-binding or enzyme substrate specificities, or to mimic the antigenic diversity found in numerous pathogens.

This article has been cited by other articles:

• Santra, S., Sun, Y., Parvani, J. G., Philippon, V., Wyand, M. S., Manson, K., Gomez-Yafal, A., Mazzara, G., Panicali, D., Markham, P. D., Montefiori, D. C., Letvin, N. L. (2007). Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors. J. Virol. 81: 8563-8570 [Abstract] [Full Text]  
• Yokokawa, J., Palena, C., Arlen, P., Hassan, R., Ho, M., Pastan, I., Schlom, J., Tsang, K. Y. (2005). Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin. Clin. Cancer Res. 11: 6342-6351 [Abstract] [Full Text]  
• Jackson, S. S., Ilyinskii, P., Philippon, V., Gritz, L., Yafal, A. G., Zinnack, K., Beaudry, K. R., Manson, K. H., Lifton, M. A., Kuroda, M. J., Letvin, N. L., Mazzara, G. P., Panicali, D. L. (2005). Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus. J. Virol. 79: 6554-6559 [Abstract] [Full Text]  
• Santra, S., Barouch, D. H., Korioth-Schmitz, B., Lord, C. I., Krivulka, G. R., Yu, F., Beddall, M. H., Gorgone, D. A., Lifton, M. A., Miura, A., Philippon, V., Manson, K., Markham, P. D., Parrish, J., Kuroda, M. J., Schmitz, J. E., Gelman, R. S., Shiver, J. W., Montefiori, D. C., Panicali, D., Letvin, N. L. (2004). Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses. Proc. Natl. Acad. Sci. USA 101: 11088-11093 [Abstract] [Full Text]  
• Palena, C., Zhu, M., Schlom, J., Tsang, K.-Y. (2004). Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells. Blood 104: 192-199 [Abstract] [Full Text]  
• Tsang, K.-Y., Palena, C., Gulley, J., Arlen, P., Schlom, J. (2004). A Human Cytotoxic T-Lymphocyte Epitope and Its Agonist Epitope from the Nonvariable Number of Tandem Repeat Sequence of MUC-1. Clin. Cancer Res. 10: 2139-2149 [Abstract] [Full Text]  
• Hodge, J. W., Poole, D. J., Aarts, W. M., Gomez Yafal, A., Gritz, L., Schlom, J. (2003). Modified Vaccinia Virus Ankara Recombinants Are as Potent as Vaccinia Recombinants in Diversified Prime and Boost Vaccine Regimens to Elicit Therapeutic Antitumor Responses. Cancer Res. 63: 7942-7949 [Abstract] [Full Text]  
• Kaur, A., Kassis, N., Hale, C. L., Simon, M., Elliott, M., Gomez-Yafal, A., Lifson, J. D., Desrosiers, R. C., Wang, F., Barry, P., Mach, M., Johnson, R. P. (2003). Direct Relationship between Suppression of Virus-Specific Immunity and Emergence of Cytomegalovirus Disease in Simian AIDS. J. Virol. 77: 5749-5758 [Abstract] [Full Text]  
• Hodge, J. W., Grosenbach, D. W., Aarts, W. M., Poole, D. J., Schlom, J. (2003). Vaccine Therapy of Established Tumors in the Absence of Autoimmunity. Clin. Cancer Res. 9: 1837-1849 [Abstract] [Full Text]  
• Evans, D. T., Chen, L.-M., Gillis, J., Lin, K.-C., Harty, B., Mazzara, G. P., Donis, R. O., Mansfield, K. G., Lifson, J. D., Desrosiers, R. C., Galan, J. E., Johnson, R. P. (2003). Mucosal Priming of Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Responses in Rhesus Macaques by the Salmonella Type III Secretion Antigen Delivery System. J. Virol. 77: 2400-2409 [Abstract] [Full Text]  
• Aarts, W. M., Schlom, J., Hodge, J. W. (2002). Vector-based Vaccine/Cytokine Combination Therapy to Enhance Induction of Immune Responses to a Self-Antigen and Antitumor Activity. Cancer Res. 62: 5770-5777 [Abstract] [Full Text]  
• Terasawa, H., Tsang, K.-Y., Gulley, J., Arlen, P., Schlom, J. (2002). Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen. Clin. Cancer Res. 8: 41-53 [Abstract] [Full Text]  
• Grosenbach, D. W., Barrientos, J. C., Schlom, J., Hodge, J. W. (2001). Synergy of Vaccine Strategies to Amplify Antigen-specific Immune Responses and Antitumor Effects. Cancer Res. 61: 4497-4505 [Abstract] [Full Text]  
• Gnjatic, S., Nagata, Y., Jager, E., Stockert, E., Shankara, S., Roberts, B. L., Mazzara, G. P., Lee, S. Y., Dunbar, P. R., Dupont, B., Cerundolo, V., Ritter, G., Chen, Y.-T., Knuth, A., Old, L. J. (2000). Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc. Natl. Acad. Sci. USA 97: 10917-10922 [Abstract] [Full Text]  
• Kaur, A., Yang, J., Hempel, D., Gritz, L., Mazzara, G. P., McClure, H., Johnson, R. P. (2000). Identification of Multiple Simian Immunodeficiency Virus (SIV)-Specific CTL Epitopes in Sooty Mangabeys with Natural and Experimentally Acquired SIV Infection. J. Immunol. 164: 934-943 [Abstract] [Full Text]  
• Hodge, J. W., Sabzevari, H., Gomez Yafal, A., Gritz, L., Lorenz, M. G. O., Schlom, J. (1999). A Triad of Costimulatory Molecules Synergize to Amplify T-Cell Activation. Cancer Res. 59: 5800-5807 [Abstract] [Full Text]  
• Conry, R. M., Khazaeli, M. B., Saleh, M. N., Allen, K. O., Barlow, D. L., Moore, S. E., Craig, D., Arani, R. B., Schlom, J., LoBuglio, A. F. (1999). Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration. Clin. Cancer Res. 5: 2330-2337 [Abstract] [Full Text]  
• Irvine, K. R., Parkhurst, M. R., Shulman, E. P., Tupesis, J. P., Custer, M., Touloukian, C. E., Robbins, P. F., Yafal, A. G., Greenhalgh, P., Sutmuller, R. P. M., Offringa, R., Rosenberg, S. A., Restifo, N. P. (1999). Recombinant Virus Vaccination against "Self" Antigens UsingAnchor-fixed Immunogens. Cancer Res. 59: 2536-2540 [Abstract] [Full Text]